SCHEMBL6401176

SCHEMBL6401176

O=C(CN1C=CN(CC(=O)c2cccc(F)c2)C1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 5/20 0.55
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
HTT P42858 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
PLA2G7 Q13093 1/20 0.44
CTNNB1 P35222 2/20 0.44
WNT3A P56704 2/20 0.44
PARP1 P09874 1/20 0.44
SCN9A Q15858 1/20 0.43
HSD11B1 P28845 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722012 0.95 GRIN2B (0.52) GRIN2BTSHRMEN1KMT2AKDM4E
SCHEMBL6399974 0.87 HTT (0.48) GRIN2BMEN1KMT2AKDM4ELMNA
SCHEMBL6404561 0.85 GRIN2B (0.45) GRIN2BMEN1KMT2ANPC1LMNA
Bromide SCHEMBL6074363 0.84 ALDH1A1 (0.49) MEN1KMT2AKDM4ENPC1LMNA
SCHEMBL6399178 0.84 ALDH1A1 (0.60) GRIN2BMEN1KMT2AKDM4ENPC1
SCHEMBL6401174 0.81 GRIN2B (0.50) GRIN2BTSHRMEN1KMT2AKDM4E
SCHEMBL29668521 0.77 HPGD (0.71) TSHRMEN1KMT2AKDM4ENPC1
SCHEMBL28346776 0.77 HPGD (0.71) TSHRMEN1KMT2AKDM4ENPC1
Hydrochloric Acid SCHEMBL3845432 0.77 ALDH1A1 (0.43) GRIN2BMEN1KMT2AKDM4ENPC1
SCHEMBL6404902 0.76 ERCC5 (0.44) GRIN2BTSHRMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272936-A1 Imidazolium cxcr3 inhibitors SMITHKLINE BEECHAM CORPORATION 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272936-A1 Imidazolium cxcr3 inhibitors CXCR3, CXCR1, CCR7 GRIN2B 1128/4885TSHR 283/4885MEN1 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.